Nutriband Inc.
NTRB Healthcare Biotechnology
Nutriband Inc.’s revenue for fiscal 2026 (year ended January 2026) was $2.0 million, down 4.80% from fiscal 2025. In the quarter to July 2026, revenue fell 29.7%, EPS grew 96.7%, free cash flow grew 55.5% and total debt fell 46.9%, each against the same quarter a year earlier.
Follow NTRB
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jan '26 | Jan '25 | Jan '24 | Jan '23 | Jan '22 | Jan '21 | Jan '20 | Jan '19 | Jan '18 | Jan '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
4.57 | 4.31 | 0.49 | 1.99 | 4.89 | 0.15 | 0.01 | 0.47 | — | 0.03 |
Receivables |
0.12 | 0.07 | 0.15 | 0.11 | 0.07 | 0.11 | 0.01 | 0.01 | 0.00 | 0.00 |
Inventory |
0.12 | 0.21 | 0.17 | 0.23 | 0.13 | 0.05 | — | — | 0.00 | 0.01 |
Total current assets |
4.99 | 4.79 | 1.02 | 2.69 | 5.47 | 0.31 | 0.04 | 0.59 | 0.16 | 0.04 |
Property, Plant, Equpment (Net) |
0.57 | 0.70 | 0.77 | 0.90 | 0.98 | 1.08 | 0.11 | 0.15 | — | — |
Goodwill and Intangible Assets (Total) |
1.92 | 1.98 | 5.69 | 5.80 | 6.28 | 8.54 | 2.03 | 2.07 | — | — |
Total non-current assets |
2.56 | 2.68 | 6.50 | 6.76 | 7.27 | 9.61 | 2.15 | 2.22 | — | — |
Total Assets |
7.55 | 7.47 | 7.52 | 9.46 | 12.74 | 9.93 | 2.20 | 2.81 | 0.16 | 0.04 |
Notes Payable |
0.13 | 0.13 | 0.13 | 0.02 | 0.01 | 1.52 | 0.24 | 0.04 | 0.03 | 0.01 |
Accounts Payable |
0.50 | 0.70 | 0.68 | 0.53 | 0.64 | 0.94 | 0.77 | 0.29 | 0.01 | 0.00 |
Current Part of Debt |
— | — | — | — | — | — | 0.07 | 0.04 | 0.03 | 0.01 |
Current Part of Capital Lease |
— | — | — | — | — | 0.02 | — | — | — | — |
Current Revenue (Deferred) |
0.12 | 0.16 | 0.16 | 0.16 | 0.11 | 0.09 | — | — | — | — |
Other current liabilities |
— | — | — | — | — | — | 0.93 | 0.07 | 0.01 | 0.00 |
Total current liabilities |
0.78 | 0.98 | 1.00 | 0.75 | 0.78 | 2.57 | 2.02 | 0.40 | 0.04 | 0.01 |
Long Term Debt (Total) |
0.04 | 0.06 | 0.08 | 0.10 | 0.10 | 0.25 | — | — | — | — |
Total non-current liabilities |
0.08 | 0.06 | 0.08 | 0.13 | 0.10 | 0.25 | — | — | — | — |
Total liabilities |
0.87 | 1.04 | 1.08 | 0.88 | 0.88 | 2.82 | 2.02 | 0.40 | 0.04 | 0.01 |
Additional Paid In Capital |
53.44 | 45.03 | 34.44 | 31.09 | 29.97 | 18.87 | 9.07 | 8.58 | 2.95 | 0.18 |
Preferred Stock (Total) |
0.00 | — | — | — | — | — | — | — | — | — |
Common Stock (Net) |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Retained Earnings |
(46.69) | (38.46) | (27.98) | (22.49) | (18.01) | (11.84) | (8.90) | (6.18) | (2.85) | (0.18) |
Treasury Stock |
0.09 | 0.15 | 0.03 | 0.03 | 0.10 | — | — | — | — | — |
Shareholders Equity (Other) |
— | — | — | — | — | 0.07 | — | — | — | — |
Common Equity (Total) |
6.68 | 6.43 | 6.44 | 8.57 | 11.86 | 7.11 | 0.18 | 2.40 | 0.12 | 0.02 |
Shareholders Equity (Total) |
6.68 | 6.43 | 6.44 | 8.57 | 11.86 | 7.11 | 0.18 | 2.40 | 0.12 | 0.02 |
Shareholders Equity and Liabilities (Total) |
7.55 | 7.47 | 7.52 | 9.46 | 12.74 | 9.93 | 2.20 | 2.81 | 0.16 | 0.04 |
Shares (Common) |
12.16 | 11.08 | 8.86 | 7.83 | 9.16 | 7.30 | 6.35 | 6.33 | 24.36 | 18.17 |
Shares (Preferred) |
3.01 | 0.00 | — | — | — | — | — | — | — | — |
Shareholders Equity (Tangible) |
4.76 | 4.45 | 0.75 | 2.77 | 5.58 | (1.42) | (1.86) | 0.33 | 0.12 | 0.02 |
Net Debt |
(4.54) | (4.25) | (0.41) | (1.88) | (4.79) | 0.09 | 0.06 | (0.43) | 0.03 | (0.02) |
Total Debt |
0.04 | 0.06 | 0.08 | 0.10 | 0.10 | 0.25 | 0.07 | 0.04 | 0.03 | 0.01 |